Paper35683033
Artemisinin Attenuates Amyloid-Induced Brain Inflammation and Memory Impairments by Modulating TLR4/NF-κB Signaling.
Zhao X and 5 others. Int J Mol Sci, 2022. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Artemisinin Attenuates Amyloid-Induced Brain Inflammation and Memory Impairments by Modulating TLR4/NF-κB Signaling. Papers, record 35683033. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35683033
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Artemisinin Attenuates Amyloid-Induced Brain Inflammation and Memory Impairments by Modulating TLR4/NF-κB Signaling.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Artemisinins | Major topic |
| Encephalitis | Major topic |
| Amyloid beta-Peptides | |
| Animals | |
| Anti-Inflammatory Agents | |
| Inflammation | |
| Memory Disorders | |
| Mice | |
| Microglia | |
| NF-kappa B | |
| Signal Transduction | |
| Toll-Like Receptor 4 |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 31771128 | National Natural Science Foundation of China | PubMed | ||
| 32070969 | National Natural Science Foundation of China | PubMed | ||
| 0127/2019/A3, 0044/2019/AGJ and 0113/2018/A3 | Science and Technology Development Fund | PubMed | ||
| MYRG2018-00134-FHS and MYRG2020-00158-FHS | University of Macau | PubMed |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24812060 | The TLR signaling adaptor TRAM interacts with TRAF6 to mediate activation of the inflammatory response by TLR4. | J Leukoc Biol | 2014 | https://conductscience.org/library/papers/24812060 | PubMed |
| 2 | 20205644 | Microglia and inflammation in Alzheimer's disease. | CNS Neurol Disord Drug Targets | 2010 | https://conductscience.org/library/papers/20205644 | PubMed |
| 3 | 17406317 | Morris water maze: procedures for assessing spatial and related forms of learning and memory. | Nat Protoc | 2006 | https://conductscience.org/library/papers/17406317 | PubMed |
| 4 | 14612454 | Identification of cathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using a functional genomics approach. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14612454 | PubMed |
| 5 | 21788993 | Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease. | Neurosci Bull | 2011 | https://conductscience.org/library/papers/21788993 | PubMed |
| 6 | 20111769 | Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents. | Chem Soc Rev | 2010 | https://conductscience.org/library/papers/20111769 | PubMed |
| 7 | 31263819 | Identification of HSP90 as a direct target of artemisinin for its anti-inflammatory activity via quantitative chemical proteomics. | Org Biomol Chem | 2019 | https://conductscience.org/library/papers/31263819 | PubMed |
| 8 | 30734970 | Farrerol attenuates MPP+ -induced inflammatory response by TLR4 signaling in a microglia cell line. | Phytother Res | 2019 | https://conductscience.org/library/papers/30734970 | PubMed |
| 9 | 28391183 | Artemisinin protects PC12 cells against β-amyloid-induced apoptosis through activation of the ERK1/2 signaling pathway. | Redox Biol | 2017 | https://conductscience.org/library/papers/28391183 | PubMed |
| 10 | 23286786 | Intrahippocampal injection of Aβ1-42 inhibits neurogenesis and down-regulates IFN-γ and NF-κB expression in hippocampus of adult mouse brain. | Amyloid | 2013 | https://conductscience.org/library/papers/23286786 | PubMed |
| 11 | 22062220 | TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury. | Am J Pathol | 2012 | https://conductscience.org/library/papers/22062220 | PubMed |
| 12 | 29158945 | NF-κB signaling in inflammation. | Signal Transduct Target Ther | 2017 | https://conductscience.org/library/papers/29158945 | PubMed |
| 13 | 12490568 | Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. | J Pharmacol Exp Ther | 2003 | https://conductscience.org/library/papers/12490568 | PubMed |
| 14 | 29414669 | COX-2 activity and expression pattern during regenerative wound healing of tail in lizard Hemidactylus flaviviridis. | Prostaglandins Other Lipid Mediat | 2018 | https://conductscience.org/library/papers/29414669 | PubMed |
| 15 | 31151322 | Artemisinin Attenuated Hydrogen Peroxide (H2O2)-Induced Oxidative Injury in SH-SY5Y and Hippocampal Neurons via the Activation of AMPK Pathway. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31151322 | PubMed |
| 16 | 15755672 | Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation. | Neurobiol Dis | 2005 | https://conductscience.org/library/papers/15755672 | PubMed |
| 17 | 16960575 | Inflammation in Alzheimer disease: driving force, bystander or beneficial response? | Nat Med | 2006 | https://conductscience.org/library/papers/16960575 | PubMed |
| 18 | 9511169 | An aluminum-induced increase in GFAP is attenuated by some chelators. | Neurotoxicol Teratol | 1998 | https://conductscience.org/library/papers/9511169 | PubMed |
| 19 | 30784077 | Metformin protects PC12 cells and hippocampal neurons from H2 O 2 -induced oxidative damage through activation of AMPK pathway. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30784077 | PubMed |
| 20 | 23386786 | Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer's disease. | Clin Interv Aging | 2013 | https://conductscience.org/library/papers/23386786 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42898534 | Antidepressant effects of artemisinin and its derivatives: a systematic review and meta-analysis of randomized controlled animal studies. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42898534 | PubMed |
| 42747247 | A Pilot Study Evaluating the Effect of Artesunate on Glymphatic-Related Fluid Transport in Parkinson's Disease Mouse Models In Vivo and Ex Vivo. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/42747247 | PubMed |
| 42506552 | Enhanced Antibacterial Activity of Artemisia absinthium Extract Containing Artemisinin and Polyphenols Loaded into Mesoporous Silica Calcium- and Cerium-Doped Nanoparticles. | J Funct Biomater | 2026 | https://conductscience.org/library/papers/42506552 | PubMed |
| 42440180 | A Combination of Artemisinin, N-acetylcysteine, Resveratrol, and Hesperidin Ameliorates Hippocampal Damage and Pathological Features in an Experimental Model of Alzheimer's Disease. | Neurochem Res | 2026 | https://conductscience.org/library/papers/42440180 | PubMed |
| 42196584 | Research Progress on Anti-Inflammatory and Antioxidant Mechanism of Artemether Based on MAPK/NF-κB Signaling Pathway. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196584 | PubMed |
| 42100327 | Modulation of programmed cell death by botanical drugs in Alzheimer's disease: a review from a traditional Chinese medicine perspective. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42100327 | PubMed |
| 41865324 | Artemisinin attenuates 3-nitropropionic acid-induced neurodegeneration via HMGB1/TLR4/NF-κB modulation in a rat model of huntington's disease. | Arch Pharm Res | 2026 | https://conductscience.org/library/papers/41865324 | PubMed |
| 41757354 | Stage-Dependent Function of Astrocytes in Alzheimer's Disease: A Review. | Neurosci Insights | 2026 | https://conductscience.org/library/papers/41757354 | PubMed |
| 41594527 | Effect of Water Extract of Artemisia annua L. on Growth Performance, Blood Biochemical Parameters and Intestinal-Related Indices in Mutton Sheep. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/41594527 | PubMed |
| 41104396 | Repurposing Artemisinin-Based Drugs from Antimalarial to Pan-Therapeutic: Pharmacological Promise and Therapeutic Challenges. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/41104396 | PubMed |
| 40919222 | DIA-based proteomics reveals anti-inflammatory role of DL-3-n-butylphthalide in cerebral small vessel disease-induced brain injury in hypertensive rat. | Transl Neurosci | 2025 | https://conductscience.org/library/papers/40919222 | PubMed |
| 40771945 | Effects of diet supplemented with water extracts of Artemisia annua L. on small intestinal immune and antioxidative indexes in lambs. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/40771945 | PubMed |
| 40297714 | Based on the Dual Pathway of Interaction-Mediated NF-κB in Cell Apoptosis and Immune Inflammation to Study the Effect of Danzhi Xiaoyao Powder on the Learning and Cognitive Ability of AD Model Rats. | Degener Neurol Neuromuscul Dis | 2025 | https://conductscience.org/library/papers/40297714 | PubMed |
| 40283970 | Artemisinin and Its Derivatives: Promising Therapeutic Agents for Age-Related Macular Degeneration. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40283970 | PubMed |
| 40220071 | Protective Effect of Artemisinin Against Luperox Induced Oxidative Stress and Insulin Resistance via Pi3k/Akt Pathway in Zebrafish Larvae. | Cell Biochem Biophys | 2025 | https://conductscience.org/library/papers/40220071 | PubMed |
| 40041897 | YOD1 regulates microglial homeostasis by deubiquitinating MYH9 to promote the pathogenesis of Alzheimer's disease. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/40041897 | PubMed |
| 40034267 | Artemisinin alleviates cisplatin-induced damage in GC-1 spermatogonia through ER stress mechanisms. | Heliyon | 2025 | https://conductscience.org/library/papers/40034267 | PubMed |
| 39936960 | Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer's Disease. | Cells | 2025 | https://conductscience.org/library/papers/39936960 | PubMed |
| 39313657 | Artemisinin Ameliorates the Neurotoxic Effect of 3-Nitropropionic Acid: A Possible Involvement of the ERK/BDNF/Nrf2/HO-1 Signaling Pathway. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/39313657 | PubMed |
| 39251858 | Artemisinin inhibits neuronal ferroptosis in Alzheimer's disease models by targeting KEAP1. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/39251858 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| GFAP | 2670 | PubTator's text mining | https://conductscience.org/library/genes/2670 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35683033
GET https://conductscience.org/api/papers/v1/35683033/references?page=2